Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways.

Area of Science:

• Immunology
• Ophthalmology
• Virology

Background:

• Herpes simplex virus 1 (HSV-1) infection can cause stromal keratitis, a leading cause of blindness.
• Understanding the inflammatory mechanisms is crucial for managing this condition.

Purpose of the Study:

• To investigate the role of lymphotoxin-alpha (LT-α) in HSV-1-induced stromal keratitis.
• To identify cellular targets and molecular pathways involved in the disease.

Main Methods:

• Analysis of LT-α and LT-β transcript levels post-infection.
• In vitro studies using corneal stromal fibroblasts to assess LT-α3 and LT-α1β2 functions.
• In vivo experiments using anti-LT-α monoclonal antibodies (mAbs) in a mouse model of stromal keratitis.

Main Results:

• High levels of LT-α and LT-β transcripts were detected 48 hours post-infection.
• LT-α3 and LT-α1β2 stimulated chemokine production in fibroblasts, indicating proinflammatory roles.
• Treatment with anti-LT-α mAb significantly reduced keratitis severity, inflammation markers, and immune cell infiltration, particularly Th1 cells.
• The efficacy of the mAb was primarily due to cell depletion, not LT-α3 activity.

Conclusions:

• Lymphotoxin-expressing cells, notably Th1 cells, play a critical role in mediating HSV-1 stromal keratitis.
• Targeting these cells offers a potential therapeutic strategy for managing this blinding eye disease.